Loading provider…
Loading provider…
Medical Oncology Physician in Newport Beach, CA
NPI: 1285602565Primary Practice Location
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
16200 Sand Canyon Ave, Irvine, CA
Primary Employer
Hoag Clinic
hoagurgentcare.com
HQ Phone
Get MD Alain's Phone Numberphone_androidMobile
Get MD Alain's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
2013 - 2027
TX State Medical License
2006 - 2026
AL State Medical License
2005 - 2025
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Fellowship • Hematology and Medical Oncology
2002 - 2003
Carol Davila University of Medicine and Pharmacy
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 85 | 206 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 56 | 193 |
| 3 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 23 | 43 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 21 | 21 |
Phase (Ph) I evaluation of the dolastatin analogue synthadotin (SYN-D; ILX651): Pooled data analysis of three alternate schedules in patients (pts) with advanced solid tumors.
Authors: Eric Rowinsky
Publication Date: 2004-07
Targeting sarcomas: novel biological agents and future perspectives.
Authors: Kevin Kelly, Kamlesh Sankhala, Monica Mita, Francis Giles
Journal: Curr Drug Targets
Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Authors: Emi Yoshida, Zachary Zumsteg, Kevin Scher, John David, Allen Ho, Nancy Lee, Stephen Shiao
Journal: Cancer
Publication Date: 2016-12-21
Lead Sponsor: ImmunoGen, Inc.
Intervention / Treatment: DRUG: Carboplatin and Etoposide, DRUG: IMGN901
Lead Sponsor: Oncolytics Biotech
Collaborators: University of Texas
Intervention / Treatment: DRUG: Carboplatin, DRUG: Paclitaxel, BIOLOGICAL: REOLYSIN
Lead Sponsor: OncoVista, Inc.
Collaborators: AAIPharma
Intervention / Treatment: DRUG: Cordycepin plus Pentostatin